Kalaris Therapeutics (KLRS) EGM 2025 summary

Opening remarks and agenda

• Meeting called to order with agenda and rules of conduct provided to all participants.

• Business described in the Notice of Special Meeting and Proxy Statement.

• Meeting held in accordance with bylaws and Delaware law.

Specific resolutions to be voted on

• Approval of an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1:15 and 1:35, at the Board's discretion, any time before January 10, 2026.

• Approval of adjournment of the meeting if additional proxies are needed for the reverse stock split proposal.

Q&A with stakeholders

• Opportunity provided for questions on proposals before voting; no questions were submitted.